<DOC>
	<DOCNO>NCT00713765</DOCNO>
	<brief_summary>The aim study 1 ) examine effect AZD3480 donepezil blood concentration 2 ) ass safety tolerability combine administration AZD3480 donepezil .</brief_summary>
	<brief_title>Pharmacokinetic Interaction Between AZD3480 Donepezil</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Provision inform consent prior studyspecific procedure BMI 18 30 kg/m2 Medical surgical history physical examination without clinically significant finding Genotyped EM , define study â‰¥ 1.5 functional CYP2D6 allele , PM , define zero functional CYP2D6 alleles History clinically significant cardio cerebrovascular , pulmonary , renal , hepatic , neurological , mental gastrointestinal disorder major disorder may interfere objective study , judge Investigator Clinically significant illness judge Investigator , within two week first administration investigational product Female subject positive pregnancy test pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>